期刊文献+

参辛胶囊质量标准研究 被引量:1

Studies on the Quality Standard of Shenxin Capsules
下载PDF
导出
摘要 目的研究复方制剂参辛胶囊的质量标准。方法采用HPLC法对参辛胶囊中的人参皂苷Rg1和人参皂苷Re进行含量测定,流动相为乙腈-0.05%磷酸溶液(95∶405),检测波长203nm。采用薄层色谱法对制剂中的主要药味人参、羚羊角、细辛等进行定性鉴别。结果人参皂苷Rg1线性范围为1.032~9.288μg(r=0.9998,n=5),平均回收率为99.76%,RSD=2.10%。人参皂苷Re线性范围为0.850~7.650μg(r=0.9998,n=5),平均回收率为96.24%,RSD=1.67%。薄层图谱斑点清晰,可鉴别出与人参、细辛对应的斑点,阴性对照无干扰。结论该方法准确、重现性好,可用于参辛胶囊的质量控制。 Objective To establish the quality standard of Shenxin Capsules. Methods The contents of ginsenoside Rg1 and ginsenoside Re in Shenxin Capsules were determined by HPLC with the mobile phase consisting of acetonitrile - 0.05 % phosphoric acid water solution (95 : 405) and UV detection wavelength at 203 nm. Qualitative analysis of Radix Ginseng, Cornu Saigae Tataricae and Herba Asari in Shenxin Capsule was carried out by TLC. Results Ginsenoside Rg1 showed a good linearity in the range of 1. 032 - 9. 288μg ( r = 0. 9998, n = 5) , the average recovery being 99.76 % and RSD being 2. 10 %. Ginsenoside Re showed a good linearity in the range of 0. 850 - 7. 650μg ( r =0. 9998, n = 5) , the average recovery being 96. 24 % and RSD being 1. 67 %. The chromatographic spots of Radix Ginseng, Cornu Saigae Tataricae and Herba Asari were identified without the interference of negative control. Conclusion The method is accurate , reproducible and can be used for the quality control of Shenxin Capsules.
出处 《中药新药与临床药理》 CAS CSCD 2006年第1期49-52,共4页 Traditional Chinese Drug Research and Clinical Pharmacology
关键词 参辛胶囊 人参皂苷RG1 人参皂苷RE HPLC法 TLC法 质量标准 Shenxin Capsules Ginsenoside Rg1 Ginsenoside Re HPLC TLC Quality Standard
  • 相关文献

参考文献4

二级参考文献25

  • 1邓洁,冯兴华.强直性脊柱炎的中西医研究思路[J].北京中医药大学学报,2000,23(S1):94-95. 被引量:8
  • 2王永发.三七总皂甙片、冲剂临床疗效概述[J].云南中医中药杂志,1996,17(3):25-27. 被引量:5
  • 3黄秦康.常用中药成分与药理手册(上册),第1版[M].北京:中国医药科技出版社,1994.132.
  • 4李玉林] 张建军 等.专题笔谈[J].中医杂志,1994,35(1):5-5.
  • 5费震宇,王文健,陈响中.三七用于冠心病治疗的药理研究[J].时珍国药研究,1997,8(1):17-18. 被引量:55
  • 6Rodell M.Metabolism of isolated fat cells. J Bio Chem, 1964,239: 375-380.
  • 7Kessler M,Acuto O,Storelli C,et al.A Modified procedure for the rapid preparation of efficiently transporting vecicle from small intestinal brush border membranes. Biochem Biophys Acta, 1978,506:136-154.
  • 8Belfrage P, Vaughan M. Simple liquid-liquid partition system for isolation of labelled oleic acid from mixture with glycerides.J Lipid Res, 1969,10:341-344.
  • 9Han LK, Kimura Y , Takaku T, et al. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int J Obes,2001,25:1459-1464.
  • 10Drent ML, Larsson I,William OT, et al. Orlistat (Ro 18-0647),a lipase inhibitor, in the treatment of human obesity:a multiple dose study. Int J Obes Relat Mitab Disord ,1995 ,19 : 221- 226.

共引文献94

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部